Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shivani Soni

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
Clinical Colorectal Cancer|June 16, 2022
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 TrialHiroyuki Arai, Joshua Millstein, Yan Yang, et al.
International Journal of Cancer|November 10, 2018
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patientsMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Oncogene|April 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapyFrancesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.
Cancers|August 29, 2024
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive ReviewKaram Ashouri, Alexandra Wong, Pooja Mittal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trialMitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
British Journal of Cancer|October 24, 2021
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Joshua Millstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyAbhimanyu S Paraskar, Shivani Soni, Kenneth T Chin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
Clinical Colorectal Cancer|June 16, 2022
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 TrialHiroyuki Arai, Joshua Millstein, Yan Yang, et al.
International Journal of Cancer|November 10, 2018
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patientsMitsukuni Suenaga, Shu Cao, Wu Zhang, et al.
Oncogene|April 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapyFrancesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.
Cancers|August 29, 2024
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive ReviewKaram Ashouri, Alexandra Wong, Pooja Mittal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trialMitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
British Journal of Cancer|October 24, 2021
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Joshua Millstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyAbhimanyu S Paraskar, Shivani Soni, Kenneth T Chin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Pageof 9